Compare Hinge Health Inc. Class A Common Stock (HNGE) vs iShares Russell 2000 ETF (IWM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs iShares Russell 2000 ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while iShares Russell 2000 ETF trades at $272.21 (market cap $75.59B). The key difference: iShares Russell 2000 ETF is far larger — about 8.9× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, iShares Russell 2000 ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and iShares Russell 2000 ETF for 83 Days on average.
| HNGE | IWM | |
|---|---|---|
Market Cap | $8.47B | $75.59B |
Volume | 1,624,526 | 37,947,395 |
Sector | Health | — |
52-Week High | $105.14 | $305.06 |
52-Week Low | $31.17 | $229.13 |
Typical Hold Time | 0 Days | 83 Days |
Enterprise Value | $8.09B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
IWM trades at $276.71, down 0.42% amid bearish technical signals with 15 sell indicators versus 2 buy signals. The ETF faces headwinds from Federal Reserve rate hikes and underperformance relative to the S&P 500 over the past decade. Recent news highlights concerns about small-cap risk premiums and competition from more selective small-cap funds.
The outlook remains challenged by interest rate sensitivity and broader market rotation away from small caps. While offering diversification from large-cap tech concentration, IWM's inclusion of unprofitable companies presents fundamental risks. Near-term performance depends on Fed policy clarity and small-cap earnings resilience.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About iShares Russell 2000 ETF
The ETF is designed to track the performance of the securities and the stocks in the Russell 2000 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.
Read more on IWM →
